GERMANY IDENTIFIES FIRST ‘MAD COW’ CASE SINCE 2009
German officials have identified one beef cow with a case of bovine spongiform encephalitis (BSE), the fatal neurological disorder also known as “Mad Cow Disease.” This is Germany’s first reported case since 2009. The cow was killed and its body destroyed, with none of the meat entering the human food chain. Health officials said that... Continue Reading
New ‘Sunshine Act’ Requirements Will Track and Publish Financial Relationships Providers Have With Healthcare Vendors
Some physicians fear disclosure of payments by drug and medical device companies could damage patient confidence and physician-patient relationships. Over the course of 2014, pathologists and medical laboratory managers will experience a different relationship with in vitro diagnostic (IVD) manufacturers and other lab industry vendors. That’s because a new federal law requires vendors to publicly disclose financial and other arrangements they have with providers. That law is the Physician Payment Sunshine Act, and it became effective on August 21, 2013. The intent of this new law is to shed light on financial aspects of relationships between physicians and healthcare vendors.Continue reading
Screen All Pregnant Women for Diabetes, Task Force Says
All pregnant women should be screened for gestational diabetes, an independent task force advised, endorsing a test that most doctors routinely perform. The U.S. Preventive Services Task Force found an overall benefit to screening and treatment, including a reduced risk of preeclampsia in pregnant patients and of having an overly large baby and birth-related injuries to the newborn. The task force’s recommendation noted that 96 percent of obstetricians screen for the condition, and that other medical groups also recommend screening. The group said women with no history of diabetes should be screened after 24 weeks of pregnancy.Continue Reading
New Blood Test for Heart Attack?
A blood test might eventually help detect the early stages of a heart attack, and another challenger to warfarin takes its case to the FDA. Early clinical results suggested that it might be possible to develop a blood test to determine who is at the highest immediate risk for a myocardial infarction.Source continue reading